yttrium radioisotopes has been researched along with ATLL in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bamford, R; Brechbiel, MW; Carrasquillo, JA; England, R; Fleisher, TA; Gansow, OA; Goldman, CK; Hanchard, B; Jackson-White, T; Jaffe, ES; Johnson, JA; Junghans, RP; Kasten-Sportes, C; Litou, H; Manns, A; Nelson, DL; Paik, CH; Reynolds, JC; Roessler, E; Top, LE; Waldmann, TA; White, JD; Zaknoen, E | 1 |
Waldmann, TA | 3 |
Brechbiel, MW; Carrasquillo, JA; Gansow, OA; Le, N; Nelson, DL; Paik, CH; Perentesis, P; Raubitschek, A; Reynolds, JC; Rotman, M; Top, LE; Waldmann, TA; White, JD | 1 |
2 review(s) available for yttrium radioisotopes and ATLL
Article | Year |
---|---|
Genetically engineered monoclonal antibodies armed with radionuclides.
Topics: Animals; Antibodies, Monoclonal; Autoimmune Diseases; Bismuth; CD4 Antigens; CD4-Positive T-Lymphocytes; Gene Expression Regulation, Neoplastic; Humans; Immunotoxins; Leukemia-Lymphoma, Adult T-Cell; Mice; Neoplasm Proteins; Neoplasms; Protein Engineering; Radioimmunodetection; Radioimmunotherapy; Radioisotopes; Yttrium Radioisotopes | 1993 |
Anti-IL-2 receptor monoclonal antibody (anti-Tac) treatment of T-cell lymphoma.
Topics: ADP Ribose Transferases; Amino Acid Sequence; Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antibody Specificity; Antibody-Dependent Cell Cytotoxicity; Bacterial Toxins; Bismuth; Exotoxins; Gene Expression Regulation, Neoplastic; HTLV-I Infections; Humans; Immunologic Deficiency Syndromes; Immunotoxins; Leukemia-Lymphoma, Adult T-Cell; Mice; Molecular Sequence Data; Neoplasm Proteins; Protein Engineering; Pseudomonas aeruginosa Exotoxin A; Radioisotopes; Receptors, Interleukin-2; Virulence Factors; Yttrium Radioisotopes | 1994 |
1 trial(s) available for yttrium radioisotopes and ATLL
Article | Year |
---|---|
Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac.
Topics: Adult; Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Female; Humans; Immunocompetence; Leukemia-Lymphoma, Adult T-Cell; Lymphocyte Count; Male; Mice; Middle Aged; Radioimmunotherapy; Receptors, Interleukin-2; T-Lymphocytes; Yttrium Radioisotopes | 1995 |
2 other study(ies) available for yttrium radioisotopes and ATLL
Article | Year |
---|---|
Human T-cell lymphotropic virus type I-associated adult T-cell leukemia. The Joseph Goldberger Clinical Investigator Lecture.
Topics: Adult; Antibodies, Monoclonal; Female; Human T-lymphotropic virus 1; Humans; Immunotoxins; Leukemia-Lymphoma, Adult T-Cell; Leukemia, T-Cell; Radioimmunotherapy; Receptors, Interleukin-2; Recombinant Fusion Proteins; Remission Induction; Structure-Activity Relationship; Yttrium Radioisotopes | 1995 |
Similarities and differences in 111In- and 90Y-labeled 1B4M-DTPA antiTac monoclonal antibody distribution.
Topics: Adult; Antibodies, Monoclonal; Chelating Agents; Female; Humans; Indium Radioisotopes; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Pentetic Acid; Radioimmunotherapy; Receptors, Interleukin-2; Yttrium Radioisotopes | 1999 |